Details for New Drug Application (NDA): 062697
NDA 062697 describes MEZLIN, which is a drug marketed by Bayer Pharms and is included in four NDAs. Additional details are available on the MEZLIN profile page.
The generic ingredient in MEZLIN is mezlocillin sodium monohydrate. There is one drug master file entry for this compound. Additional details are available on the mezlocillin sodium monohydrate profile page.
The generic ingredient in MEZLIN is mezlocillin sodium monohydrate. There is one drug master file entry for this compound. Additional details are available on the mezlocillin sodium monohydrate profile page.
Summary for 062697
| Tradename: | MEZLIN |
| Applicant: | Bayer Pharms |
| Ingredient: | mezlocillin sodium monohydrate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062697
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 3GM BASE/VIAL | ||||
| Approval Date: | Jan 22, 1987 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 4GM BASE/VIAL | ||||
| Approval Date: | Jan 22, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
